Algert Global’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2M | Sell |
60,390
-55,930
| -48% | -$1.85M | 0.04% | 636 |
|
|
2025
Q1 | $4.68M | Buy |
116,320
+57,640
| +98% | +$2.32M | 0.12% | 301 |
|
|
2024
Q4 | $2.76M | Buy |
58,680
+10,010
| +21% | +$471K | 0.06% | 500 |
|
|
2024
Q3 | $2.57M | Sell |
48,670
-22,738
| -32% | -$1.2M | 0.07% | 476 |
|
|
2024
Q2 | $3.87M | Buy |
71,408
+27,738
| +64% | +$1.5M | 0.13% | 250 |
|
|
2024
Q1 | $3.06M | Sell |
43,670
-150
| -0.3% | -$10.5K | 0.12% | 288 |
|
|
2023
Q4 | $3.66M | Buy |
43,820
+28,370
| +184% | +$2.37M | 0.15% | 223 |
|
|
2023
Q3 | $455K | Buy |
+15,450
| New | +$455K | 0.02% | 773 |
|
|
2023
Q1 | – | Sell |
-39,143
| Closed | -$1.79M | – | 1167 |
|
|
2022
Q4 | $1.79M | Hold |
39,143
| – | – | 0.1% | 329 |
|
|
2022
Q3 | $1.9M | Buy |
39,143
+5,917
| +18% | +$287K | 0.11% | 286 |
|
|
2022
Q2 | $1.31M | Buy |
33,226
+358
| +1% | +$14.1K | 0.1% | 365 |
|
|
2022
Q1 | $1.21M | Buy |
32,868
+27,948
| +568% | +$1.03M | 0.08% | 441 |
|
|
2021
Q4 | $224K | Buy |
+4,920
| New | +$224K | 0.03% | 816 |
|
|
2021
Q1 | – | Sell |
-36,684
| Closed | -$762K | – | 457 |
|
|
2020
Q4 | $762K | Buy |
+36,684
| New | +$762K | 0.22% | 164 |
|
|
2019
Q4 | – | Sell |
-14,388
| Closed | -$164K | – | 395 |
|
|
2019
Q3 | $164K | Buy |
+14,388
| New | +$164K | 0.06% | 293 |
|
|
2015
Q4 | – | Sell |
-73,181
| Closed | -$490K | – | 334 |
|
|
2015
Q3 | $490K | Hold |
73,181
| – | – | 0.27% | 145 |
|
|
2015
Q2 | $492K | Hold |
73,181
| – | – | 0.27% | 136 |
|
|
2015
Q1 | $496K | Sell |
73,181
-4,669
| -6% | -$31.6K | 0.28% | 149 |
|
|
2014
Q4 | $624K | Buy |
77,850
+48,910
| +169% | +$392K | 0.37% | 107 |
|
|
2014
Q3 | $102K | Buy |
28,940
+9,190
| +47% | +$32.4K | 0.08% | 264 |
|
|
2014
Q2 | $94K | Buy |
+19,750
| New | +$94K | 0.06% | 277 |
|